Apoptotic pathways in the pathogenesis of pemphigus: Targets for new therapies

Current Pharmaceutical Biotechnology

Volumn 13, Issue 10, 2012, Pages 1877-1881

  Lotti, Roberta ^a   Marconi, Alessandra ^a   Pincelli, Carlo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Acantholysis; Antibodies; Apoptosis; Caspases; Desmoglein; FasL; Pemphigus

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3 INHIBITOR; CASPASE 7 INHIBITOR; CASPASE INHIBITOR; FAS LIGAND; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ACANTHOLYSIS; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; BLISTER; HUMAN; NONHUMAN; PATHOGENESIS; PEMPHIGUS;

ACANTHOLYSIS; ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOANTIBODIES; FAS LIGAND PROTEIN; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KERATINOCYTES; MOLECULAR TARGETED THERAPY; PEMPHIGUS;

EID: 84866724886     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112802273236     Document Type: Article

References (58)

1. Amagai, M. Autoimmune and infectious skin diseases that target desmogleins. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci., 2010, 86(5), 524-537.
2. Eyre, R.W.; Stanley, J.R. Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients. J. Exp Med., 1987, 165(6), 1719-1724.
3. Amagai, M.; Klaus-Kovtun, V.; Stanley, J.R. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991, 67(5),869-877.
4. Ding, X.; Aoki, V.; Mascaro, J.M. Jr; Lopez-Swiderski, A.; Diaz, L.A.; Fairley, J.A. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J. Invest. Dermatol., 1997, 109(4),592-596.
5. Perez, O.A.; Patton, T. Novel therapies for pemphigus vulgaris: an overview. Drugs Aging., 2009, 26(10), 833-846.
6. Amagai, M.; Ahmed, A.R.; Kitajima, Y.; Bystryn, J.C.; Milner, Y.; Gniadecki, R.; Hertl, M.; Pincelli, C.; Kurzen, H.; Fridkis-Hareli, M.; Aoyama, Y.; Frusi-Zlotkin, M.; Müller, E.; David, M.; Mimouni, D.; Vind-Kezunovic, D.; Michel, B.; Mahoney, M.; Grando, S. Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"? Exp. Dermatol., 2006, 15(10), 815-831.
7. Stanley, J.R.; and Amagai, M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N. Engl. J. Med., 2006, 355 1800-1810.
8. Nguyen, V.T.; Ndoye, A.; Grando, S.A. Pemphigus vulgaris antibody identifies pemphaxin. A novel keratinocyte annexin-like molecule binding acetylcholine. J. Biol. Chem., 2000, 275(38), 29466-29476.
9. Nguyen, V.T.; Ndoye, A.; Grando, S.A. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am. J. Pathol., 2000, 157(4), 1377-13791.
10. Marchenko, S.; Chernyavsky, A.I.; Arredondo, J.; Gindi, V.; Grando, S.A. Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology. J. Biol. Chem., 2010, 285(6), 3695-3704.
11. Aoyama, Y.; Kitajima, Y. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J. Invest. Dermatol. 1999, 112(1), 67-71.
12. Koch, P.J.; Mahoney, M.G.; Ishikawa, H.; Pulkkinen, L.; Uitto, J.; Shultz, L.; Murphy, G.F.; Whitaker-Menezes, D.; Stanley, J.R. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J. Cell Biol., 1997, 137 1091-1102.
13. Seishima, M.; Esaki, C.; Osada, K.; Mori, S.; Hashimoto, T.; Kitajima, Y. Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. J. Invest. Dermatol., 1995, 104 33-37.
14. Aoyama, Y.; Owada, M.K.; Kitajima, Y. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur. J. Immunol., 1999, 29, 2233-2240.
15. Chernyavsky, A.I.; Arredondo, J.; Kitajima, Y.; Sato-Nagai, M.; Grando, S.A. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J. Biol. Chem. 2007, 282 13804-13812.
16. Berkowitz, P.; Hu, P.; Liu, Z.; Diaz, L.A.; Enghild, J.J.; Chua, M.P.; Rubenstein, D.S. Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J. Biol. Chem., 2005, 280(25), 23778-23784.
17. Berkowitz, P.; Hu, P.; Warren, S.; Liu, Z.; Diaz, L.A.; Rubenstein, D.S. p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc. Natl. Acad. Sci. USA 2006, 103(34), 12855-12860.
18. Frusi-Zlotkin, M.; Raichenberg, D.; Wang, X.; David, M.; Michel, B.; Milner, Y. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor. Autoimmunity, 2006, 39 563-575.
19. Pretel, M.; España, A.; Marquina, M.; Pelacho, B.; López-Picazo, J.M.; López-Zabalza, M.J. An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris. Exp. Dermatol 2009, 18 771-780.
20. Grando, S.A.; Bystryn, J.C.; Chernyavsky, A.I.; Frusi-Zlotkin, M.; Gniadecki, R.; Lotti, R.; Milner, Y.; Pittelkow, M.R.; Pincelli, C. Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis. Exp. Dermatol., 2009, 18(9), 764-770.
21. Sato, M.; Aoyama, Y.; Kitajima, Y. Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab. Invest. 2000, 80 1583-1592.
22. Gliem, M.; Heupel, W.M.; Spindler, V.; Harms, G.S.; Waschke, J. Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris. Am. J. Physiol. Cell Physiol. 2010, 299(3), C606-613.
23. Schmidt, E.; Gutberlet, J.; Siegmund, D.; Berg, D.; Wajant, H.; Waschke J. Apoptosis is not required for acantholysis in pemphigus vulgaris. Am. J. Physiol. Cell Physiol., 2009, 296(1), C162-172.
24. Puviani, M.; Marconi, A.; Cozzani, E.; Pincelli, C. Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8. J. Invest. Dermatol., 2003, 120(1), 164-167.
25. Gniadecki, R.; Jemec, G.B.; Thomsen, B.M.; Hansen, M. Relationship between keratinocyte adhesion and death: anoikis in acantholytic diseases. Arch. Dermatol. Res., 1998, 290(10), 528-532.
26. Pacheco-Tovar, M.G.; Avalos-Díaz, E.; Vega-Memije, E.; Bollainy-Goytia, J.J.; López-Robles, E.; Hojyo-Tomoka, M.T.; Domínguez-Soto, L.; Herrera-Esparza, R. The final destiny of acantholytic cells in pemphigus is Fas mediated. J. Eur. Acad. Dermatol. Venereol., 2009, 23(6), 697-701.
27. Li, N.; Zhao, M.; Wang, J.; Liu, Z.; Diaz, L.A. Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin. J. Immunol., 2009, 182(1), 711-717.
28. Pelacho, B.; Natal, C.; España, A.; Sánchez-Carpintero, I.; Iraburu, M.J.; López-Zabalza, M.J. Pemphigus vulgaris autoantibodies induce apoptosis in HaCaT keratinocytes. FEBS Lett., 2004, 566(1-3), 6-10.
29. Wang, X.; Brégégère, F.; Frusi-Zlotkin, M.; Feinmesser, M.; Michel, B.; Milner Y. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis 2004, 9(2), 131-143.
30. Arredondo, J.; Chernyavsky, A.I.; Karaouni, A.; Grando, S.A. Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus. Am. J. Pathol., 2005, 167(6), 1531-1544.
31. Cirillo, N.; Lanza, M.; Femiano, F.; Gaeta, G.M.; De Rosa, A.; Gombos, F.; Lanza, A. If pemphigus vulgaris IgG are the cause of acantholysis, new IgG-independent mechanisms are the concause. J. Cell Physiol., 2007, 212(3), 563-567.
32. D'Auria, L.; Bonifati, C.; Mussi, A.; D'Agosto, G.; De Simone, C.; Giacalone, B.; Ferraro, C.; Ameglio, F. Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity. Eur. Cytokine. Netw., 1997, 8(4), 383-387.
33. Siebra, M.X.; Santos, MA.; Almeida, T.L.; Leite, A.C.; Cunha, F.Q.; Rocha, F.A. Evidence for the participation of nitric oxide in pemphigus. Braz. J. Med. Biol. Res., 2006, 39(5), 671-675.
34. Grando, S.A.; Glukhenky, B.T.; Drannik, G.N.; Kostromin, A.P.; Chernyavsky, A.I. Cytotoxic proteases in blister fluid of pemphigus and pemphigoid patients. Int. J. Tissue React. 1989, 11(4), 195-201.
35. Kroemer, G.; Galluzzi, L.; Vandenabeele, P.; Abrams, J.; Alnemri, E.S.; Baehrecke, E.H.; Blagosklonny, M.V.; El-Deiry, W.S.; Golstein, P.; Green. D.R.; Hengartner, M.; Knight, R.A.; Kumar, S.; Lipton, S.A.; Malorni, W.; Nuñez, G.; Peter, M.E.; Tschopp, J.; Yuan, J.; Piacentini, M.; Zhivotovsky, B.; Melino, G.; Nomenclature Committee on Cell Death 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ., 2009, 16(1), 3-11.
36. Danial, N.N.; Korsmeyer, S.J. Cell death: critical control points. Cell, 2004, 116(2), 205-219.
37. Itoh, N.; Nagata, S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem., 1993, 268(15), 10932-10937.
38. Tartaglia, L.A.; Pennica, D.; Goeddel, D.V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem., 1993, 268(25), 18542-18548.
39. Muzio, M.; Chinnaiyan, A.M.; Kischkel, F.C.; O'Rourke, K.; Shevchenko, A.; Ni, J.; Scaffidi, C.; Bretz, J.D.; Zhang, M.; Gentz, R.; Mann, M.; Krammer, P.H.; Peter, M.E.; Dixit, V.M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell 1996, 85(6), 817-827.
40. Kischkel, F.C.; Hellbardt, S.; Behrmann, I.; Germer, M.; Pawlita, M.; Krammer, P.H.; Peter, M.E. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J., 1995, 14(22), 5579-5588.
41. Muzio, M.; Stockwell, B.R.; Stennicke, H.R.; Salvesen, G.S.; Dixit, V.M. An induced proximity model for caspase-8 activation. J. Biol. Chem., 1998, 273(5), 2926-2930.
42. Matsue, H.; Kobayashi, H.; Hosokawa, T.; Akitaya, T.; Ohkawara, A. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes. Arch. Dermatol. Res., 1995, 287(3-4), 315-320.
43. Viard-Leveugle, I.; Bullani, R.R.; Meda, P.; Micheau, O.; Limat, A.; Saurat, J.H.; Tschopp, J.; French, L.E. Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. J. Biol. Chem., 2003, 278(18), 16183-16188.
44. Hill, L.L.; Ouhtit, A.; Loughlin, S.M.; Kripke, M.L.; Ananthaswamy, H.N.; Owen-Schaub, L.B. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science, 1999, 285(5429), 898-900.
45. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998, 282(5388), 490-493.
46. Baker, M.B.; Altman, N.H.; Podack, E.R.; Levy, R.B. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med., 1996, 183(6), 2645-2656.
47. Braun, M.Y.; Lowin, B.; French, L.; Acha-Orbea, H.; Tschopp, J. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med., 1996, 183(2), 657-661.
48. Sayama, K.; Yonehara, S.; Watanabe, Y.; Miki, Y. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J. Invest. Dermatol., 1994, 103(3), 330-334.
49. Orlov, M.D.; Chernyavsky, A.I.; Arredondo, J.; Grando, S.A. Synergistic actions of pemphigus vulgaris IgG, Fas-ligand and tumor necrosis factor-alpha during induction of basal cell shrinkage and acantholysis. Autoimmunity 2006, 39(7), 557-562.
50. Weiske, J.; Schöneberg, T.; Schröder, W.; Hatzfeld, M.; Tauber, R.; Huber, O. The fate of desmosomal proteins in apoptotic cells. J. Biol. Chem., 2001, 276 41175-41181.
51. Dusek, R.L.; Getsios, S.; Chen, F.; Park, J.K.; Amargo, E.V.; Cryns, V.L.; Green, K.J. The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J. Biol. Chem., 2006, 281 3614-3624.
52. Iordanov, M.S.; Sundholm, A.J.; Simpson, E.L.; Hanifin, J.M.; Ryabinina, O.P.; Choi, R.J.; Korcheva, V.B.; Schneider, P.; Magun, B.E. Cell death-induced activation of epidermal growth factor receptor in keratinocytes: implications for restricting epidermal damage in dermatitis. J. Invest. Dermatol., 2005, 125(1), 134-142.
53. Berkowitz, P.; Chua, M.; Liu, Z.; Diaz, L.A.; Rubenstein, D.S. Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin. Am. J. Pathol., 2008, 173(6), 1628-1636.
54. Lee, H.E.; Berkowitz, P.; Jolly, P.S.; Diaz, L.A.; Chua, M.P.; Rubenstein, D.S. Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis. J. Biol. Chem., 2009, 284(18), 12524-12532.
55. Farley, N.; Pedraza-Alva, G.; Serrano-Gomez, D.; Nagaleekar, V.; Aronshtam, A.; Krahl, T.; Thornton, T.; Rincón, M. p38 mitogenactivated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T cells. Mol. Cell Biol., 2006, 26(6), 2118-2129.
56. Rosen, K.; Shi, W.; Calabretta, B.; Filmus, J. Cell detachment triggers p38 mitogen-activated protein kinase-dependent overexpression of Fas ligand. A novel mechanism of Anoikis of intestinal epithelial cells. J. Biol. Chem., 2002, 277(48), 46123-46130.
57. Garmyn, M.; Mammone, T.; Pupe, A.; Gan, D.; Declercq, L.; Maes, D. Human keratinocytes respond to osmotic stress by p38 map kinase regulated induction of HSP70 and HSP27. J. Invest. Dermatol., 2001, 117(5),1290-1295.
58. Hsu, S.C.; Gavrilin, M.A.; Tsai, M.H.; Han, J.; Lai, M.Z. p38 mitogen-activated protein kinase is involved in Fas ligand expression. J. Biol. Chem., 1999, 274(36), 25769-25776.